Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Br J Surg ; 106(3): 286-295, 2019 02.
Article in English | MEDLINE | ID: mdl-30325504

ABSTRACT

BACKGROUND: Few studies have assessed changes in antihypertensive and lipid-lowering therapy after bariatric surgery. The aim of this study was to assess the 6-year rates of continuation, discontinuation or initiation of antihypertensive and lipid-lowering therapy after bariatric surgery compared with those in a matched control group of obese patients. METHODS: This nationwide observational population-based cohort study used data extracted from the French national health insurance database. All patients undergoing gastric bypass or sleeve gastrectomy in France in 2009 were matched with control patients. Mixed-effect logistic regression models were used to analyse factors that influenced discontinuation or initiation of treatment over a 6-year interval. RESULTS: In 2009, 8199 patients underwent primary gastric bypass (55·2 per cent) or sleeve gastrectomy (44·8 per cent). After 6 years, the proportion of patients receiving antihypertensive and lipid-lowering therapy had decreased more in the bariatric group than in the control group (antihypertensives: -40·7 versus -11·7 per cent respectively; lipid-lowering therapy: -53·6 versus -20·2 per cent; both P < 0·001). Gastric bypass was the main predictive factor for discontinuation of therapy for hypertension (odds ratio (OR) 9·07, 95 per cent c.i. 7·72 to 10·65) and hyperlipidaemia (OR 11·91, 9·65 to 14·71). The proportion of patients not receiving treatment at baseline who were subsequently started on medication was lower after bariatric surgery than in controls for hypertension (5·6 versus 15·8 per cent respectively; P < 0·001) and hyperlipidaemia (2·2 versus 9·1 per cent; P < 0·001). Gastric bypass was the main protective factor for antihypertensives (OR 0·22, 0·18 to 0·26) and lipid-lowering medication (OR 0·12, 0·09 to 0·15). CONCLUSION: Bariatric surgery is associated with a good discontinuation of antihypertensive and lipid-lowering therapy, with gastric bypass being more effective than sleeve gastrectomy.


Subject(s)
Antihypertensive Agents/therapeutic use , Bariatric Surgery/statistics & numerical data , Hypolipidemic Agents/therapeutic use , Adult , Case-Control Studies , Drug Substitution , Female , Gastrectomy/statistics & numerical data , Gastric Bypass/statistics & numerical data , Humans , Male , Obesity/surgery
2.
Gastroenterol Res Pract ; 2016: 2570237, 2016.
Article in English | MEDLINE | ID: mdl-27242898

ABSTRACT

Background. Bariatric surgery is an important field of surgery. An important complication of bariatric surgery is dumping syndrome (DS). Aims. To evaluate the incidence of DS in patients undergoing bariatric surgery. Methods. 541 patients included from 5 nutrition and bariatric centers in France underwent either LSG or LRYGB. They were evaluated at 1 month (M1) and 6 months (M6) postoperatively by an interview and completion of a dumping syndrome questionnaire. Results. 268 patients underwent LSG (Group A) and 273 underwent LRYGB. From the LRYGB patients 229 had mechanical gastrojejunoanal anastomosis with 30 mm linear stapler (Group B) and 44 had manual (hand sewn) 15 mm gastrojejunal anastomosis (Group C). Overall incidence of DS was 8.5% at M1 and M6. In LSG group (Group A), only 4 patients (1.49%) reported episodes of DS at M1 and 3 (1.12%) at M6. In Group B, 41 patients (17.90%) reported episodes of DS at M1 and 43 (18.78%) at M6. Group C experienced one case (2.27%) of DS at M1 and none (0%) at M6. Conclusions. Patients undergoing LRYGB, especially with larger gastrojejunal anastomosis, are more prone to developing DS following surgery than patients undergoing LSG or LRYGB with calibrated manual anastomosis.

3.
Obes Surg ; 26(8): 1710-6, 2016 08.
Article in English | MEDLINE | ID: mdl-26677058

ABSTRACT

BACKGROUND: Gastric leaks and bleeding are the most important complications after laparoscopic sleeve gastrectomy (LSG). The use of absorbable membranes as staple line reinforcement may decrease this risk. On the other hand, these materials bring additional costs and their economic impact is not well known. The purpose of this study was to assess the clinical and economic performance of one of the commercially available buttressing absorbable materials when treating a high-risk population. METHODS: A retrospective, observational, and comparative study was conducted at Montpellier University Hospital, France, between July 2013 and September 2014. Patients undergoing LSG, who were at a high risk for leaks and bleeding, were included and treated according to two groups: no buttressing (July 2013 to January 2014) and buttressing (February 2014 to September 2014). Clinical and economic outcomes were measured throughout the first 6 months. RESULTS: Two hundred two patients were included in the study: 116 during the no stapling reinforcement period and 86 during the buttressing period. Baseline characteristics were similar. There was no significant difference between the two groups regarding gastric leaks. However, buttressing reduced hemorrhagic complications (0 vs 8.6 %, p = 0.005) and decreased average total hospital costs for the first hospitalization (5768 vs 6025 €, p < 0.001), as well as 6-month total inpatient cost (5944 vs. 6246 €, p < 0.001). CONCLUSIONS: Staple line reinforcement with absorbable material reduces bleeding in high-risk population. Therefore, this type of material can also result in cost-savings.


Subject(s)
Anastomotic Leak/prevention & control , Gastrectomy/adverse effects , Laparoscopy/adverse effects , Obesity, Morbid/surgery , Surgical Stapling/statistics & numerical data , Weight Loss , Absorbable Implants , Cost-Benefit Analysis , Female , France , Humans , Male , Middle Aged , Retrospective Studies , Risk Assessment , Surgical Stapling/economics , Surgical Stapling/methods , Sutures
4.
Diagn Interv Imaging ; 96(9): 947-51, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25686774

ABSTRACT

PURPOSE: To assess the performance of routine esophagogastric transit studies (OGT) performed between day 2 (D2) and day 4 (D4) following sleeve gastrectomy for the diagnosis of gastric fistula. PATIENTS AND METHODS: Single center study including 736 patients undergoing surgery for sleeve gastrectomy including 32 of whom developed gastric fistula. Seven hundred and twenty OGT on D2 and 86 abdominal and pelvic CT scans were performed to investigate for a fistula and whether or not a blood collection was present. Sensitivity, specificity, positive and negative predictive values, Youden index (YI) and dosimetry were calculated for both investigations. RESULTS: The sensitivity and specificity of OGT for the diagnosis of fistula were 7% and 98% respectively with a PPV of 18%, an NPV of 96% and YI of 0.06. The mean DSP was 5500µGy.m(2). Sensitivity, specificity, positive and negative predictive values and Youden index for CT were 55%, 100%, 100%, 81%, 0.55, respectively for the presence of a fistula; and 96%, 86%, 78%, 98%, 0.83 for the presence of a non-blood collection and; 100%, 86%, 78%, 100%, 0.86 for the presence of a non-blood collection and/or fistula. The mean DLP was 3700 mGy.cm. CONCLUSION: Because of its very poor sensitivity for the diagnosis of gastric fistula, the OGT on D2 needs to be reconsidered. CT performed on clinical suspicion appears to be a better diagnostic tool.


Subject(s)
Fluoroscopy/methods , Gastric Fistula/diagnostic imaging , Gastrointestinal Transit/physiology , Gastroplasty/methods , Laparoscopy/methods , Postoperative Complications/diagnostic imaging , Adolescent , Adult , Aged , Anastomotic Leak/diagnostic imaging , Humans , Middle Aged , Radiation Dosage , Retrospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed , Young Adult
5.
Obes Surg ; 23(8): 1341-3, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23722525

ABSTRACT

Laparoscopic sleeve gastrectomy (LSG) has become one of the most common bariatric procedures. Even so, the gastric leak remains the most feared complication with a difficult, non-standardized treatment. The purpose of this study was to assess the feasibility of a new classification of leakage after LSG used in Montpellier University Hospital. We have studied the correlations between radiological findings and therapeutic outcome for the 20 gastric leaks. The presence of a leak was evaluated according to the day of appearance, the symptomatology, the location, severity on the CT scan, and the management. From May 2010 to September 2012, we prospectively collected data from 20 patients diagnosed with gastric leak after LSG. There were 16 women and 4 men with a mean age of 34 years old (range 21-52 years old). The fistula was diagnosed at postoperative day 28.1 days (range 3-77 days). Patients were grouped by the new classification in: 11-type I, 6-type II, 3-type III fistula, and 0-type IV. The visualization of leakage was observed for five cases (25 %). The initial surgical drainage was performed for 11 cases and the conservative treatment was preferred in 9 cases. Three cases necessitated a delayed surgical drainage after 1 week of conservative treatment. The surgical drainage was performed by laparoscopy in 12 cases and by laparotomy in 2 cases. The new CT scan classification of gastric leak could serve as a working basis for a consensus on the therapeutic management of this dreaded complication.


Subject(s)
Anastomotic Leak/diagnostic imaging , Gastrectomy , Gastric Fistula/diagnostic imaging , Laparoscopy , Obesity, Morbid/surgery , Tomography, X-Ray Computed , Adult , Algorithms , Anastomotic Leak/surgery , Body Mass Index , C-Reactive Protein/metabolism , Contrast Media , Feasibility Studies , Female , France/epidemiology , Gastrectomy/adverse effects , Gastric Fistula/surgery , Humans , Incidence , Laparoscopy/adverse effects , Male , Middle Aged , Obesity, Morbid/complications , Obesity, Morbid/diagnostic imaging , Postoperative Period , Reoperation , Surgical Stapling
6.
J Visc Surg ; 150(1): 52-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23137644

ABSTRACT

Abdominal wall incisional and inguinal hernia repair can call for utilization of implants or prostheses as an alternative to simple suture techniques. The various implants can be synthetic, biologic or mixed: their physicochemical properties condition the mechanical results and the long-term outcome of the repair. The increasing number of available materials allows the surgeon to choose between a wide variety depending on the indication, the site of implantation, the surgical approach and whether the operative field is contaminated or not. With regard to evidence-based medicine, while several synthetic implants have been shown to be superior in efficacy to simple suture, other studies are underway to develop the indications for bioprostheses, in particular in contaminated fields. This review of the literature summarizes the current knowledge on synthetic and biologic implants (physicochemical characteristics, forms, indications).


Subject(s)
Bioprosthesis , Hernia, Abdominal/surgery , Herniorrhaphy/instrumentation , Surgical Mesh , Acellular Dermis , Biocompatible Materials , Biomechanical Phenomena , Humans
7.
J Visc Surg ; 149(2): e104-14, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22261580

ABSTRACT

INTRODUCTION: Post-operative adhesions after gastrointestinal surgery are responsible for significant morbidity and constitute an important public health problem. The aim of this study was to review the surgical literature to determine the incidence, consequences and the variety of possible countermeasures to prevent adhesion formation. METHODS: A systematic review of English and French language surgical literature published between 1995 and 2009 was performed using the keywords "adhesion" and "surgery". RESULTS: Peritoneal adhesions are reported as the cause of 32% of acute intestinal obstruction and 65-75% of all small bowel obstructions. It is estimated that peritoneal adhesions develop after 93-100% of upper abdominal laparotomies and after 67-93% of lower abdominal laparotomies. Nevertheless, only 15-18% of these adhesions require surgical re-intervention. The need for re-intervention for adhesion-related complications varies depending on the initial type of surgery, the postoperative course and the type of incision. The laparoscopic approach appears to decrease the risk of adhesion formation by 45% and the need for adhesion-related re-intervention to 0.8% after appendectomy and to 2.5% after colorectal surgery. At the present time, only one product consisting of hyaluronic acid applied to a layer of carboxymethylcellulose (Seprafilm(®)) has been shown to significantly reduce the incidence of postoperative adhesion formation; but this product is also associated with a significant increase in the incidence of anastomotic leakage when the membrane is applied in direct contact with the anastomosis. The use of this product has not been shown to decrease the risk of re-intervention for bowel obstruction. CONCLUSIONS: The prevention of postoperative adhesions is an important public health goal, particularly in light of the frequency of this complication. The routine use of anti-adhesion products is not recommended given the lack of studies with a high level of evidence concerning their efficacy and safety of use.


Subject(s)
Digestive System Surgical Procedures , Peritoneal Diseases/etiology , Postoperative Complications , Tissue Adhesions/etiology , Humans , Hyaluronic Acid/therapeutic use , Intestinal Obstruction/epidemiology , Intestinal Obstruction/etiology , Intestinal Obstruction/prevention & control , Intestinal Obstruction/surgery , Laparoscopy , Laparotomy , Membranes, Artificial , Peritoneal Diseases/epidemiology , Peritoneal Diseases/prevention & control , Peritoneal Diseases/surgery , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Postoperative Complications/surgery , Tissue Adhesions/epidemiology , Tissue Adhesions/prevention & control , Tissue Adhesions/surgery
8.
Ann Endocrinol (Paris) ; 70(4): 242-5, 2009 Sep.
Article in French | MEDLINE | ID: mdl-19166991

ABSTRACT

The Zollinger-Ellison syndrome is due to an endocrine gastrin-secreting tumor, the gastrinoma. This tumor is often malignant and patients develop metastases in 25% of cases. The usual localizations of gastrinomas are at the head of the pancreas, the duodenal wall and the peripancreatic lymph nodes. Ectopic localizations, such as stomach, small bowel, gallbladder, liver or ovaries, are rare. We report the case of an intrahepatic gastrinoma, surgically treated by left hepatectomy. Upon review of scientific literature, we found 19 cases of intrahepatic gastrinoma. This diagnosis is always difficult to establish, even after a complete preoperative imaging and an extensive operative search for a possible primary tumor. The best evidence for diagnosis is the gastrinemia decreasing to a normal range after liver resection, and the absence of recurrence in long-term follow-up.


Subject(s)
Gastrinoma/surgery , Laparoscopy/methods , Liver Neoplasms/surgery , Adult , Diagnosis, Differential , Gastrinoma/diagnostic imaging , Humans , Liver Neoplasms/diagnostic imaging , Male , Radiography , Treatment Outcome
9.
Surg Endosc ; 23(9): 1955-60, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19067068

ABSTRACT

BACKGROUND: The TANTALUS system (MetaCure Ltd.) is a minimally invasive implantable gastric stimulation modality that does not exhibit malabsorptive or restrictive characteristics. The device applies gastric contractility modulation (GCM) signals to the stomach antrum. The signals are delivered in synchronization to the native electrical activity of the stomach during meals. Retrospective analysis of previous studies indicated that type 2 diabetes mellitus (T2DM) subjects on oral medication with hemoglobin A1c (HbA1c) between 7.5% and 9.5% are the population with most potential benefit from the treatment. The current study includes subjects enrolled prospectively within that range of HbA1c. AIM: To prospectively investigate the potential effect of the TANTALUS system on glycemic control and weight in overweight subjects with T2DM. METHODS: In this European multicenter, open-label study, 13 T2DM obese (6 male, 7 female, BMI 37.2 +/- 1.0 kg/m(2), range 30.4-44.0 kg/m(2)) subjects treated with oral antidiabetic medications but with poor glycemic control (HbA1c > or = 7%, range 7.3-9.5%) were implanted laparoscopically with the TANTALUS system. RESULTS: Thirteen subjects that had completed 3 months of treatment showed a significant reduction in HbA1c from 8.0 +/- 0.2% to 6.9 +/- 0.1% (p < 0.05), whereas fasting blood glucose decreased from 175 +/- 6 mg/dL to 127 +/- 8 mg/dL (p < 0.05). The glycemic improvement was accompanied by reduction in weight from 104.4 +/- 4.4 kg to 99.7 +/- 4.8 kg, and in waist circumference from 122.3 +/- 3.2 cm to 117.0 +/- 3.0 cm. CONCLUSIONS: Interim results with the TANTALUS system suggest that this stimulation regime can potentially improve glucose levels and induce moderate weight loss in obese T2DM subjects on oral antidiabetic therapy with poor glycemic control. Further evaluation is required to determine whether this effect is due to induced weight loss and/or due to direct signal-dependent mechanisms.


Subject(s)
Diabetes Mellitus, Type 2/therapy , Electric Stimulation Therapy , Glycated Hemoglobin/analysis , Obesity/therapy , Afferent Pathways/physiology , Blood Pressure , Combined Modality Therapy , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Electrodes, Implanted , Feasibility Studies , Female , Gastrointestinal Motility , Humans , Hypoglycemic Agents/therapeutic use , Laparoscopy , Male , Obesity/complications , Prospective Studies , Pyloric Antrum , Waist Circumference
10.
Diabetes Metab ; 35(6 Pt 2): 524-7, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20152738

ABSTRACT

Laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) are two bariatric procedures approved for the management of morbidly obese patients. According to a meta-analysis of all obese patients who underwent bariatric procedures, 11% also had type 2 diabetes mellitus (T2DM) before surgery, and improvement or resolution of this co-morbidity was highlighted in many of the studies. However, the mechanism(s) of action underlying such an effect with the various types of bariatric procedure remain unclear. Also, in terms of weight loss, the most efficient operations are those that come with a high rate of morbidity. This means that the choice of procedure is best done after a multidisciplinary team discussion with the patient in an effort to predict the beneficial effects and risks of each possible procedure. However, for years now, the bariatric team at Montpellier Hospital has preferred either LSG or LGBP as the treatment of choice for morbidly obese patients with T2DM, given the higher rates of failure with LAGB over time compared with the excellent results achieved by both LSG and LGBP in many studies.


Subject(s)
Diabetes Mellitus, Type 2/surgery , Gastrectomy/methods , Laparoscopy , Obesity, Morbid/surgery , Diabetes Mellitus, Type 2/complications , Humans , Obesity, Morbid/complications , Treatment Outcome , Weight Loss
11.
J Gynecol Obstet Biol Reprod (Paris) ; 37(8): 796-8, 2008 Dec.
Article in French | MEDLINE | ID: mdl-18653289

ABSTRACT

We report the case of a 43-year-old woman, who presented a complete and non-reductible ileo-cecal intussusception with pre-occlusion. An ileocecal resection with ileocolic anastomosis was performed. The pathologic examination confirmed the diagnosis of colic endometriosis with transmural lesions, causing the intussusception. Altough the digestive endometriosis is quite classical and well-known, particulary with vermiform appendix and rectosigmoïd involvement, ileo-cecal intussusception secondary to endometriosis is rare.


Subject(s)
Cecal Diseases/complications , Endometriosis/complications , Ileal Diseases/etiology , Ileocecal Valve , Intussusception/etiology , Adult , Anastomosis, Surgical , Cecal Diseases/diagnosis , Cecal Diseases/surgery , Endometriosis/diagnosis , Endometriosis/surgery , Female , Humans , Ileal Diseases/diagnosis , Ileal Diseases/surgery , Intussusception/diagnosis , Intussusception/surgery , Treatment Outcome
13.
Obes Surg ; 18(5): 560-5, 2008 May.
Article in English | MEDLINE | ID: mdl-18317859

ABSTRACT

BACKGROUND: Good results obtained after laparoscopic sleeve gastrectomy (LSG), in terms of weight loss and morbidity, have been reported in few recent studies. Our team has designed a multicenter prospective study for the evaluation of the effectiveness and feasibility of this operation as a restrictive procedure. METHODS: From January 2003 to September 2006, 163 patients (68% women) with an average age of 41.57 years, were operated on with a LSG. Indications for this procedure were morbid obese [body mass index (BMI)>40 kg/m2] or severe obese patients (BMI>35 kg/m2) with severe comorbidities (diabetes, sleep apnea, hypertension...) with high-volume eating disorders and superobese patients (BMI>50 kg/m2). RESULTS: The average BMI was 45.9 kg/m2. Forty-four patients (26.99%) were superobese, 84 (51.53%) presented with morbid obesity, and 35 (21.47%) were severe obese patients. Prospective evaluations of excess weight loss, mortality, and morbidity have been analyzed. Laparoscopy was performed in 162 cases (99.39%). No conversion to laparotomy had to be performed. There was no operative mortality. Perioperative complications occurred in 12 cases (7.36%). The reoperation rate was 4.90% and the postoperative morbidity was 6.74% due to six gastric fistulas (3.66%), in which four patients (2.44%) had a previous laparoscopic adjustable gastric banding. Long-term morbidity was caused by esophageal reflux symptoms (11.80%). The percentage of loss in excessive body weight was 48.97% at 6 months, 59.45% at 1 year (120 patients), 62.02% at 18 months, and 61.52% at 2 years (98 patients). No statistical difference was noticed in weight loss between obese and extreme obese patients. CONCLUSIONS: The sleeve gastrectomy seems to be a safe and effective restrictive bariatric procedure to treat morbid obesity in selected patients. LSG may be proposed for volume-eater patients or to prepare superobese patients for laparoscopic gastric bypass or laparoscopic duodenal switch. However, weight regained, quality of life, and evolution ofmorbidities due to obesity need to be evaluated in a long-term follow up.


Subject(s)
Gastrectomy/methods , Adult , Feasibility Studies , Gastroplasty , Humans , Laparoscopy , Obesity, Morbid/epidemiology , Obesity, Morbid/surgery , Prospective Studies , Reoperation , Treatment Failure , Treatment Outcome , Weight Loss
14.
Obes Surg ; 18(5): 569-72, 2008 May.
Article in English | MEDLINE | ID: mdl-18340499

ABSTRACT

BACKGROUND: The surgical treatment of morbid obesity by laparoscopic adjustable gastric banding has become a "gold standard" in Europe. Currently, five types of silicone bands are used in the majority of countries performing bariatric surgery. METHODS: The MIDBAND was introduced to the European market in 2000. It is placed around the stomach using the Pars Flaccida technique described by Forsell. A prospective multicentric study on 113 cases was carried out to evaluate technical feasibility, complications, and the midterm weight loss outcomes (2 years). RESULTS: The percentage of excess body weight loss was 52.58% at 2 years. Perioperative mortality was nil and the complication rate was low (slippage <2%). CONCLUSION: These encouraging results require longer-term studies to validate this procedure.


Subject(s)
Gastroplasty/methods , Adult , Female , Gastroplasty/instrumentation , Humans , Laparoscopy , Male , Obesity, Morbid/surgery , Treatment Outcome
15.
Surg Endosc ; 21(8): 1373-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17356945

ABSTRACT

BACKGROUND: Nowadays, laparoscopic adrenalectomy is the "gold standard" procedure for the treatment of benign lesions. However, the situation is not so clearcut when the issue is laparoscopic excision of malignant adrenal tumors. We present our results of laparoscopic adrenalectomy for treating malignant tumors over the past decade. METHODS: Between October 1995 and June 2004, 131 consecutive laparoscopic adrenalectomies were performed on 120 patients (11 synchronous bilateral procedures). All patients underwent a standardized investigation protocol during their workup for surgery. RESULTS: There were only two conversions to laparotomy (1.6%). Complications that occurred during the procedure were limited to six patients (5%). Postoperative 30-days mortality was nil. Postoperative complications occurred in five patients (4.7%) during the first 30 days of recovery. The median hospital stay for all patients was 2.5 days (range = 2-10 days). Twelve patients (9%) had a malignant tumor: nine corticoadrenalomas, one pleomorphic sarcoma, one metastatic deposit from a previously excised colonic cancer, and one malignant pheochromocytoma. At mean followup of 34 months, mean survival time was 42.3 months for corticoadrenalomas that had undergone laparoscopy versus 29.7 months for those who had had a laparotomy. Five of the nine patients are alive and well at a mean of 37 months following surgery. One patient developed pulmonary metastases one year postsurgery; they were responsive to mitotane. Five years later, the same patient had a reoperation for an intra-abdominal retrogastric recurrence of her tumor and continues to do well. Another patient developed pulmonary metastases 22 months following adrenalectomy. Two patients died of metastatic intra-abdominal disease 20 and 7 months postsurgery. CONCLUSION: When laparoscopic surgery is to used for cancer treatment, caution is the rule to maintain the primary objective of securing a survival rate at least as high as that for open surgery, without increased risk of recurrence. Considering the results presented within this study, it seems that the laparoscopic removal of a corticoadrenaloma should not worsen the prognosis, provided the surgeon respects the primary rules of oncologic resectional surgery. Any surgical conditions that would preclude the strict application of these criteria are contraindications to a laparoscopic procedure.


Subject(s)
Adrenal Cortex Neoplasms/surgery , Adrenalectomy , Laparoscopy , Adolescent , Adrenalectomy/methods , Adrenocortical Adenoma/surgery , Adult , Aged , Female , Humans , Laparoscopy/methods , Male , Middle Aged
16.
Surg Endosc ; 21(6): 870-4, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17103270

ABSTRACT

BACKGROUND: The commonest surgical procedure for management of morbid obesity in Europe is laparoscopic adjustable gastric banding (LAGB), even though laparoscopic vertical banded gastroplasty (LVBG) is still considered to be a gold standard restrictive option in bariatric surgery. A multicenter prospective study was designed to to assess the efficacy of LVBG in terms of weight loss and complication rates for obese patients who have indications for a restrictive procedure. PATIENTS AND METHODS: Two-hundred morbidly obese patients (84.5% female) with a mean age of 41 years and mean body mass index (BMI) of 43.2 kg/m(2) underwent LVBG as described by MacLean. Five trocars were placed in standard positions as per laparoscopic upper gastrointestinal surgery. A vertical gastric pouch (30 ml) was created with circular (21 or 25mm) and endolinear stapling techniques, enabling definitive separation of the two parts of the stomach. The gastric outlet was calibrated with either a polypropylene mesh (5.5 cm in length and 1cm in width) or a nonadjustable silicone band. The median follow-up period was 30 months (range, 1-72 months). RESULTS: One case had to be converted to open surgery (gastric perforation) and there was one death secondary to peritonitis of unknown etiology. The morbidity rate was 24%, comprising the following complications: gastric outlet stenosis (8%); staple line leak (2.5%); food trapping (1.5%); peritonitis (1%); thrombophlebitis (1.5%); pulmonary embolism (0.5%); and gastroesophageal reflux (9%). The excess weight loss achieved was 56.7% (1 year), 68.3% (2 years), and 65.1% (3 years). CONCLUSIONS: Laparoscopic vertical banded gastroplasty is an effective procedure for the surgical management of morbid obesity, especially for patients who present hyperphagia but are unable to manage the constraints of adjustable gastric banding. Laparoscopic vertical banded gastroplasty is safe, as demonstrated by an acceptable complication rate, of which gastric outlet stenosis, staple line leakage, and gastroesophageal reflux predominate.


Subject(s)
Gastroplasty , Adult , Female , Gastroplasty/adverse effects , Humans , Laparoscopy , Male , Obesity, Morbid/surgery , Postoperative Complications , Prospective Studies , Treatment Outcome , Weight Loss
17.
Int J Obes (Lond) ; 30(7): 1104-10, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16477271

ABSTRACT

BACKGROUND: Although adjustable gastric banding is increasingly proposed for massively obese patients, little is known about the modifications of resting metabolic rate and substrate oxidation or about metabolic determinants of weight loss following this type of bariatric surgery. OBJECTIVES: To evaluate the relationships between excess weight loss, resting metabolic rate (RMR) and substrate oxidation, and to identify metabolic predictive factors of weight loss after adjustable gastric banding. SUBJECTS: Seventy-three obese nondiabetic women aged 39.1+/-10.4 years (18.4-64.8). DESIGN: Resting metabolic rate and substrate oxidation (indirect calorimetry), body composition (bio-impedance), lipid profile and insulin sensitivity indexes were assessed before and after (13.3+/-6.0 months, range 6.0-31.1) adjustable gastric banding. Patients were classified according to postsurgery time: group A (6-12 months, n=39); group B (12-18 months, n=21); group C (>18 months, n=13). Metabolic parameters associated with the percentage of excess weight lost (EWL) 1 year after surgery were analyzed in univariate and multivariate regressions. RESULTS: Mean weight loss was 26.2+/-11.4 kg. Mean fat mass loss was 17.3+/-8.1 kg. All biological parameters associated with excess weight improved after surgery. Excess weight lost at 1 year was 45.9+/-17.1% in group A, 47.4+/-17.1% in group B and 51.4+/-18.5% in group C (P=NS). Resting metabolic rate/fat-free mass (FFM) slightly decreased (28.9+/-3.26 vs 30.3+/-2.8, P<0.00001) and RMR/body weight slightly increased (18.5+/-2.8 vs 17.3+/-1.9, P<0.00001) after surgery. Respiratory quotient (0.81+/-0.06 vs 0.82+/-0.05) and FFM-adjusted lipid oxidation (1.10+/-0.41 vs 1.05+/-0.33 mg/min/kg FFM) were not significantly modified after surgery. In multiple linear regression analysis, difference in RMR/body weight, difference in energy sparing, baseline BMI and postsurgery time, were significantly and independently correlated with EWL (total R2=72.5%). CONCLUSIONS: Adjustable gastric banding promotes gradual but sustained weight loss and is associated with long-term conservation of lipid oxidation and energy expenditure. The individual variability in energy sparing mechanisms predicts weight loss during the first year after surgery.


Subject(s)
Basal Metabolism , Obesity, Morbid/surgery , Weight Loss , Adolescent , Adult , Anthropometry/methods , Body Composition , Calorimetry, Indirect , Energy Metabolism , Female , Follow-Up Studies , Gastroplasty , Humans , Lipid Metabolism , Middle Aged , Obesity, Morbid/physiopathology , Oxidation-Reduction , Postoperative Period , Prognosis , Treatment Outcome
19.
J Radiol ; 86(12 Pt 1): 1763-72, 2005 Dec.
Article in French | MEDLINE | ID: mdl-16333225

ABSTRACT

PURPOSE: To evaluate the role of imaging for follow-up after treatment of morbid obesity by laparoscopic adjustable gastric banding (LAGB). PATIENTS AND METHODS: Since 1996, more than 1,000 patients underwent gastric banding using 5 different types of devices. Our experience is based on a retrospective study (from September 1996 to September 2002) concerning 663 consecutive patients who underwent LAGB: 114 Lapband system (LB) and 549 Swedish adjustable gastric banding (SAGB). Upper gastrointestinal series were performed within 24-48 hours after surgery in all patients. Radiological examination was also used to detect complications and to adjust gastric band. RESULTS: The five types of gastric band are easily identified on plain films. Early and late complications are illustrated: pouch dilatation, slippage, band migration, rotation of the port, and system disconnection. Radiological criteria for adjustment of gastric band are explained on the basis of barium studies performed before and after any modification of the stoma size. CONCLUSION: In patients treated with LAGB for morbid obesity, radiology plays an important role in evaluating early and late complications.


Subject(s)
Gastroplasty/methods , Laparoscopy , Obesity, Morbid/surgery , Adult , Equipment Design , Follow-Up Studies , Gastroplasty/instrumentation , Humans , Obesity, Morbid/diagnostic imaging , Radiography
20.
Surg Endosc ; 19(7): 947-50, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15920690

ABSTRACT

BACKGROUND: Experience was gained management of intra-gastric migration of adjustable gastric banding. METHODS: From July 1996 to January 2003, 4236 patients who underwent laparoscopic adjustable gastric banding were proposed for routine follow-up. Gastrograms were performed in case of band adjustment. Radiological controls and endoscopy were performed according to symptoms. RESULTS: A total of 45 cases of band migration (1.6%) were diagnosed during follow-up. All but one of the migrated bands were removed laparoscopically either by a dissection outside the stomach or through a short gastrotomy. Mortality was 0% and morbidity 8% (n = 4). CONCLUSION: The risk of an intragastric band migration remains low in the literature but could grow on account of the longer follow-up of patients. The retrieval of the band is the gold standard and must be planned promptly or delayed according to symptoms.


Subject(s)
Foreign-Body Migration/epidemiology , Gastroplasty/adverse effects , Adolescent , Adult , Gastroplasty/methods , Humans , Laparoscopy , Middle Aged , Obesity, Morbid/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...